Tyme Technologies Inc. (TYME)

[mcsharkey]

Here's where we stand on Canxer trials. Hannuman. I have some info on Dumurjian below.

Still has over 20Millian shares. He and Hoffman
Got some links down below for study material data Mat0! On a scheduling note, just at the beginning of this CALENDAR YEAR, our board of directors were telling us the second half of 2020 was going to be our rocket-to-the moon. So I figured we'd be at least to countdown on the blast-off by now.

Before that, of the five trials list raised all sorts of problems and died on the vine. Successful breast cancer trial, without enough funding to properly complete. Da.... shame on that. Actual these first three links are three sides of the coin on that stalled, under-fund breast cancer study.
***************************************************
Links on BREAST CANCER
(1) Here is our wunder-ful wunder-ful positive testimonial link:
https://people.com/bodies/head-of-the-class-khrystyne-haje-recovered-stage-iv-breast-cancer/

(2) This link will get you a fairly succinct piece of where we were viewed ahh, negatively.
https://ihatebreastcancer.wordpress.com/2017/04/13/khrystyne-haje-and-the-sm-88-story/.

(3) This third one is the market perspective on the downfall that led to Red Bank Mike Demurgian's departure.
https://www.fool.com/investing/2019/01/18/heres-why-tyme-technologies-fell-35-on-friday.aspx#:~:text=Shares%20of%20Tyme%20Technologies%20(NASDAQ,patients%20with%20advanced%20pancreatic%20cancer.
***************************************************
Link to Clinical trials.gov site. Will takes a little time to practice with on what you play around trying to dig through the fields that will raise some questions in your mind. My method to use hitting on our Investor Relations rep, Brian Gill.

(1) https://clinicaltrials.gov/ct2/results?cond=&term=sm-88&cntry=&state=&city=&dist=&number=Link

That'll get you to status tables for all five. Play around on the top tool bar to view the fields you want. This next link is pretty cool to play with. Shows one study (the CT number for Clinical Trial ID reference).

You can compare the versions of all the data tables on each trial. I encourage you and all to play with it.

(2) https://clinicaltrials.gov/ct2/history//NCT03512756
*******************************************************
So we're in 2021 4th Qrtr. TYME's FY 2022. April supposed to be blast off April.

Head of the Class's Khrystyne Haje is in recovery from stage IV breast cancer after doctors initially gave her just two years to live
Head of the Class's Khrystyne Haje is in recovery from stage IV breast cancer after doctors initially gave her just two years to live